{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:16:40Z","timestamp":1788905800215,"version":"build-2803163510"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001774","name":"The University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.cytogfr.2020.04.001","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T21:42:34Z","timestamp":1587073354000},"page":"109-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Multifactorial effects of hyperglycaemia, hyperinsulinemia and inflammation on bone remodelling in type 2 diabetes mellitus"],"prefix":"10.1016","volume":"55","author":[{"given":"V.A.","family":"Shahen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gerbaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Koeppenkastrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.F.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.E.","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda N.L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.Y.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.B.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.C.","family":"Brennan-Speranza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i3.10","article-title":"Osteoclasts have multiple roles in bone in addition to bone resorption","volume":"19","author":"Boyce","year":"2009","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"12","key":"10.1016\/j.cytogfr.2020.04.001_bib0010","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/MCB.01428-09","article-title":"Osteocyte Wnt\/beta-catenin signaling is required for normal bone homeostasis","volume":"30","author":"Kramer","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/bonekey.2013.215","article-title":"Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit","volume":"3","author":"Sims","year":"2014","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fendo.2015.00041","article-title":"coupling signals between the osteoclast and osteoblast: how are messages transmitted between these temporary visitors to the bone surface?","volume":"6","author":"Sims","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"issue":"9","key":"10.1016\/j.cytogfr.2020.04.001_bib0030","first-page":"2709","article-title":"Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures","volume":"80","author":"Nguyen","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.cytogfr.2020.04.001_bib0035","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00198-005-1909-1","article-title":"Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study","volume":"16","author":"de","year":"2005","journal-title":"Osteoporos. Int."},{"issue":"12","key":"10.1016\/j.cytogfr.2020.04.001_bib0040","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.metabol.2014.09.002","article-title":"Type 2 diabetes mellitus and fracture risk","volume":"63","author":"Dede","year":"2014","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","article-title":"Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies","volume":"27","author":"Ma","year":"2012","journal-title":"Eur. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00223-015-0100-8","article-title":"Bone microarchitecture in men and women with diabetes: the importance of cortical porosity","volume":"98","author":"Paccou","year":"2016","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12902-017-0224-0","article-title":"Low bone turnover in premenopausal women with type 2 diabetes mellitus as an early process of diabetes-associated bone alterations: a cross-sectional study","volume":"17","author":"Purnamasari","year":"2017","journal-title":"BMC Endocr. Disord."},{"issue":"12","key":"10.1016\/j.cytogfr.2020.04.001_bib0060","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/aps.2017.23","article-title":"Association of bone turnover markers with glucose metabolism in Chinese population","volume":"38","author":"Wang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.cytogfr.2020.04.001_bib0065","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3892\/mmr.2014.2430","article-title":"Decreased osteoclastogenesis, osteoblastogenesis and low bone mass in a mouse model of type 2 diabetes","volume":"10","author":"Xu","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00592-011-0347-0","article-title":"Serum levels of bone resorption markers are decreased in patients with type 2 diabetes","volume":"50","author":"Reyes-Garcia","year":"2013","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12891-016-1228-z","article-title":"Influence of high glucose and advanced glycation end-products (ages) levels in human osteoblast-like cells gene expression","volume":"17","author":"Miranda","year":"2016","journal-title":"BMC Musculoskelet. Disord."},{"issue":"9","key":"10.1016\/j.cytogfr.2020.04.001_bib0080","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.bbagen.2015.05.020","article-title":"Role of receptor for advanced glycation end products in the complication and progression of various types of cancers","volume":"1850","author":"Malik","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0085","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","article-title":"Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE","volume":"280","author":"Wautier","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.cytogfr.2020.04.001_bib0090","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.2337\/db16-0053","article-title":"Regulation of glucose handling by the skeleton: insights from mouse and human studies","volume":"65","author":"Liu","year":"2016","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.cytogfr.2020.04.001_bib0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00045391-200607000-00012","article-title":"A review of types 1 and 2 diabetes mellitus and their treatment with insulin","volume":"13","author":"Salsali","year":"2006","journal-title":"Am. J. Ther."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/db12-0337","article-title":"Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes","volume":"62","author":"Mashili","year":"2013","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0105","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1210\/en.2008-1487","article-title":"Potential role of growth hormone in impairment of insulin signaling in skeletal muscle, adipose tissue, and liver of rats chronically treated with arginine","volume":"150","author":"de Castro Barbosa","year":"2009","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1359\/jbmr.2002.17.2.200","article-title":"Leptin inhibits osteoclast generation","volume":"17","author":"Holloway","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.cytogfr.2020.04.001_bib0115","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1759720X16687480","article-title":"Diabetes and bone health: latest evidence and clinical implications","volume":"9","author":"Sundararaghavan","year":"2017","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/ALN.0b013e3181799d45","article-title":"Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms","volume":"109","author":"Martyn","year":"2008","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.cytogfr.2020.04.001_bib0130","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1074\/jbc.273.6.3308","article-title":"Hyperglycemic levels of glucose inhibit interleukin 1 release from RAW 264.7 murine macrophages by activation of protein kinase C","volume":"273","author":"Hill","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/iid3.97","article-title":"Acute hyperglycemia impairs IL-6 expression in humans","volume":"4","author":"Spindler","year":"2016","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2172-13-19","article-title":"High glucose concentrations induce TNF-alpha production through the down-regulation of CD33 in primary human monocytes","volume":"13","author":"Gonzalez","year":"2012","journal-title":"BMC Immunol."},{"issue":"8","key":"10.1016\/j.cytogfr.2020.04.001_bib0145","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1464-5491.2004.01296.x","article-title":"C-reactive protein, its role in inflammation, type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones","volume":"21","author":"Nesto","year":"2004","journal-title":"Diabet. Med."},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0150","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1749-6632.2009.05315.x","article-title":"Functions of nuclear factor kappaB in bone","volume":"1192","author":"Boyce","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0155","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semnephrol.2007.01.006","article-title":"AGE, RAGE, and ROS in diabetic nephropathy","volume":"27","author":"Tan","year":"2007","journal-title":"Semin. Nephrol."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4161\/derm.22028","article-title":"Advanced glycation end products: Key players in skin aging?","volume":"4","author":"Gkogkolou","year":"2012","journal-title":"Dermatoendocrinol"},{"issue":"6","key":"10.1016\/j.cytogfr.2020.04.001_bib0165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11914-016-0332-1","article-title":"Advanced glycation end products, diabetes, and bone strength","volume":"14","author":"Yamamoto","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0170","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/138945009787122905","article-title":"Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - are these receptors valid therapeutic targets","volume":"10","author":"Sourris","year":"2009","journal-title":"Curr. Drug Targets"},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.cytogfr.2020.04.001_bib0180","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jc.2007-1817","article-title":"Clinical review: the role of advanced glycation end products in progression and complications of diabetes","volume":"93","author":"Goh","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0185","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00198-005-2035-9","article-title":"The role of collagen in bone strength","volume":"17","author":"Viguet-Carrin","year":"2006","journal-title":"Osteoporos. Int."},{"issue":"Suppl 2","key":"10.1016\/j.cytogfr.2020.04.001_bib0190","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0020-1383(16)47003-8","article-title":"Bone mechanical properties and changes with osteoporosis","volume":"47","author":"Osterhoff","year":"2016","journal-title":"Injury"},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.32098\/mltj.03.2014.07","article-title":"The role of collagen crosslinks in ageing and diabetes - the good, the bad, and the ugly","volume":"4","author":"Snedeker","year":"2014","journal-title":"Muscles Ligaments Tendons J."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0200","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.biocel.2003.09.006","article-title":"Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix","volume":"36","author":"McCarthy","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.cytogfr.2020.04.001_bib0205","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1074\/jbc.M610536200","article-title":"Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation","volume":"282","author":"Valcourt","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0210","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.3892\/mmr.2017.6278","article-title":"Wnt-beta-catenin signaling pathway inhibition by sclerostin may protect against degradation in healthy but not osteoarthritic cartilage","volume":"15","author":"Wu","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbrc.2015.02.091","article-title":"Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells","volume":"461","author":"Tanaka","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0220","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bone.2006.09.011","article-title":"Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways","volume":"40","author":"Alikhani","year":"2007","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","article-title":"Oxidative stress and antioxidant defense","volume":"5","author":"Birben","year":"2012","journal-title":"World Allergy Organ. J."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/157339911797415585","article-title":"The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach","volume":"7","author":"Folli","year":"2011","journal-title":"Curr. Diabetes Rev."},{"issue":"11","key":"10.1016\/j.cytogfr.2020.04.001_bib0235","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1515\/CCLM.2008.302","article-title":"Oxidative stress, free radicals and bone remodeling","volume":"46","author":"Banfi","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"issue":"10","key":"10.1016\/j.cytogfr.2020.04.001_bib0240","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.molmed.2009.08.004","article-title":"Oxidative stress in bone remodelling and disease","volume":"15","author":"Wauquier","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0245","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2003.12.073","article-title":"Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB","volume":"314","author":"Bai","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.cytogfr.2020.04.001_bib0250","doi-asserted-by":"crossref","first-page":"778","DOI":"10.2337\/db12-0073","article-title":"Insulin resistance and type 2 diabetes","volume":"61","author":"Taylor","year":"2012","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.cytogfr.2020.04.001_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027617","article-title":"Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates","volume":"6","author":"Kamath","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl 11","key":"10.1016\/j.cytogfr.2020.04.001_bib0260","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199200111-00002","article-title":"Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web","volume":"20","author":"DeFronzo","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-014-9931-y","article-title":"Osteocalcin: an osteoblast-derived polypeptide hormone that modulates whole body energy metabolism","volume":"96","author":"Brennan-Speranza","year":"2015","journal-title":"Calcif. Tissue Int."},{"issue":"9","key":"10.1016\/j.cytogfr.2020.04.001_bib0270","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/apm.12247","article-title":"Forkhead transcription factor FOXO1 inhibits nuclear factor-kappaB in gastric cancer","volume":"122","author":"Yu","year":"2014","journal-title":"APMIS"},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0275","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","article-title":"Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism","volume":"142","author":"Ferron","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0280","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cell.2010.06.002","article-title":"Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition","volume":"142","author":"Fulzele","year":"2010","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.cytogfr.2020.04.001_bib0285","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2016-1726","article-title":"Association between insulin resistance and bone structure in nondiabetic postmenopausal women","volume":"101","author":"Shanbhogue","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"40","key":"10.1016\/j.cytogfr.2020.04.001_bib0290","doi-asserted-by":"crossref","first-page":"31055","DOI":"10.1074\/jbc.M109.079962","article-title":"Foxo1, a novel regulator of osteoblast differentiation and skeletogenesis","volume":"285","author":"Teixeira","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0295","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.bone.2011.01.019","article-title":"FOXO1 modulates osteoblast differentiation","volume":"48","author":"Siqueira","year":"2011","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0300","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cmet.2010.01.001","article-title":"FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts","volume":"11","author":"Rached","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13578-017-0154-6","article-title":"Epigenetic regulation of Runx2 transcription and osteoblast differentiation by nicotinamide phosphoribosyltransferase","volume":"7","author":"Ling","year":"2017","journal-title":"Cell Biosci."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0310","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0092-8674(03)00002-3","article-title":"Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity","volume":"112","author":"Sosic","year":"2003","journal-title":"Cell"},{"issue":"Suppl 1","key":"10.1016\/j.cytogfr.2020.04.001_bib0315","first-page":"43","article-title":"Interleukin-6 and related cytokines: effect on the acute phase reaction","volume":"37","author":"Heinrich","year":"1998","journal-title":"Z. Ernahrungswiss."},{"issue":"16","key":"10.1016\/j.cytogfr.2020.04.001_bib0320","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/febs.13709","article-title":"The JAK\/STAT pathway in obesity and diabetes","volume":"283","author":"Gurzov","year":"2016","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0325","article-title":"STAT3 activation: a key factor in tumor immunoescape","volume":"2","author":"Rebe","year":"2013","journal-title":"JAKSTAT"},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0330","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0167-4889(02)00321-X","article-title":"Molecular basis of the cell specificity of cytokine action","volume":"1592","author":"Ishihara","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.cytogfr.2020.04.001_bib0335","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI0215617","article-title":"Stat proteins and oncogenesis","volume":"109","author":"Bromberg","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0340","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.immunol.22.091003.090312","article-title":"The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response","volume":"22","author":"Alexander","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0345","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0083-6729(08)00621-3","article-title":"Interleukin-6 and insulin resistance","volume":"80","author":"Kim","year":"2009","journal-title":"Vitam. Horm."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0350","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/MCB.24.1.258-269.2004","article-title":"Essential role of STAT3 in body weight and glucose homeostasis","volume":"24","author":"Cui","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.cytogfr.2020.04.001_bib0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047493","article-title":"Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3)","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"issue":"57","key":"10.1016\/j.cytogfr.2020.04.001_bib0360","doi-asserted-by":"crossref","first-page":"96958","DOI":"10.18632\/oncotarget.18555","article-title":"Role of the JAK2\/STAT3 signaling pathway in the pathogenesis of type 2 diabetes mellitus with macrovascular complications","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0365","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2337\/db12-0443","article-title":"Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity","volume":"62","author":"Jorgensen","year":"2013","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.cytogfr.2020.04.001_bib0370","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00125-010-1786-9","article-title":"The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion","volume":"53","author":"Lebrun","year":"2010","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.cytogfr.2020.04.001_bib0375","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1387\/ijdb.041816fl","article-title":"Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues","volume":"48","author":"Liu","year":"2004","journal-title":"Int. J. Dev. Biol."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0380","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bone.2011.04.020","article-title":"Osteoblast\/osteocyte-specific inactivation of Stat3 decreases load-driven bone formation and accumulates reactive oxygen species","volume":"49","author":"Zhou","year":"2011","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.cytogfr.2020.04.001_bib0385","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/endo.137.4.8625884","article-title":"Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells","volume":"137","author":"Levy","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0390","first-page":"369","article-title":"Inactivation of Stat3 decreases bone response to mechanical loading","volume":"40","author":"Li","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0395","first-page":"177","article-title":"Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies","volume":"3","author":"Tawara","year":"2011","journal-title":"Cancer Manag. Res."},{"issue":"10","key":"10.1016\/j.cytogfr.2020.04.001_bib0400","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/intimm\/dxq431","article-title":"IL-1 plays an important role in the bone metabolism under physiological conditions","volume":"22","author":"Lee","year":"2010","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0405","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jbmr.5650060212","article-title":"Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro","volume":"6","author":"Akatsu","year":"1991","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0410","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4049\/jimmunol.0803007","article-title":"The mechanism of osteoclast differentiation induced by IL-1","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.cytogfr.2020.04.001_bib0415","doi-asserted-by":"crossref","first-page":"11535","DOI":"10.1074\/jbc.M607999200","article-title":"Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways","volume":"283","author":"Yoshitake","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.cytogfr.2020.04.001_bib0420","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resorption","volume":"145","author":"Ishimi","year":"1990","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0425","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.182.5.1461","article-title":"Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors","volume":"182","author":"Udagawa","year":"1995","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cytogfr.2020.04.001_bib0430","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00774-013-0514-1","article-title":"IL-6 negatively regulates osteoblast differentiation through the SHP2\/MEK2 and SHP2\/Akt2 pathways in vitro","volume":"32","author":"Kaneshiro","year":"2014","journal-title":"J. Bone Miner. Metab."},{"issue":"4","key":"10.1016\/j.cytogfr.2020.04.001_bib0435","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jamcollsurg.2014.07.738","article-title":"IL-6 levels are inversely related to blood glucose levels in severe sepsis and septic shock","volume":"219","author":"Jaehne","year":"2014","journal-title":"J. Am. Coll. Surg."},{"issue":"6","key":"10.1016\/j.cytogfr.2020.04.001_bib0440","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2337\/dc07-2243","article-title":"Hypoglycemia increases serum interleukin-6 levels in healthy men and women","volume":"31","author":"Dotson","year":"2008","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0445","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","article-title":"TNF alpha and the TNF receptor superfamily: structure-function relationship(s)","volume":"50","author":"Idriss","year":"2000","journal-title":"Microsc. Res. Tech."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0450","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(95)01272-9","article-title":"TNF-alpha inhibits glucose-induced insulin secretion in a pancreatic beta-cell line (INS-1)","volume":"377","author":"Zhang","year":"1995","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0455","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","article-title":"Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes","volume":"27","author":"Pickup","year":"2004","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.cytogfr.2020.04.001_bib0460","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.cytogfr.2020.04.001_bib0465","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.173.8.4838","article-title":"Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo","volume":"173","author":"Kitaura","year":"2004","journal-title":"J. Immunol."},{"issue":"35","key":"10.1016\/j.cytogfr.2020.04.001_bib0470","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1016\/S0021-9258(19)61511-5","article-title":"Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis","volume":"275","author":"Abu-Amer","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0475","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3803\/EnM.2015.30.1.35","article-title":"NF-kappaB-Mediated regulation of osteoclastogenesis","volume":"30","author":"Boyce","year":"2015","journal-title":"Endocrinol. Metab. Seoul (Seoul)"},{"issue":"9","key":"10.1016\/j.cytogfr.2020.04.001_bib0480","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00198-013-2313-x","article-title":"NF-kappaB signaling and bone resorption","volume":"24","author":"Abu-Amer","year":"2013","journal-title":"Osteoporos. Int."},{"issue":"9","key":"10.1016\/j.cytogfr.2020.04.001_bib0485","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1359\/jbmr.2001.16.9.1593","article-title":"Tumor necrosis factor alpha-induced osteoclastogenesis requires tumor necrosis factor receptor-associated factor 6","volume":"16","author":"Kaji","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"1-2","key":"10.1016\/j.cytogfr.2020.04.001_bib0490","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1043-4666(03)00106-6","article-title":"Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor","volume":"22","author":"Abbas","year":"2003","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.cytogfr.2020.04.001_bib0495","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cbf.2801","article-title":"Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK","volume":"30","author":"Zhang","year":"2012","journal-title":"Cell Biochem. Funct."},{"issue":"10","key":"10.1016\/j.cytogfr.2020.04.001_bib0500","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1074\/jbc.M507804200","article-title":"Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways","volume":"281","author":"Lu","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cytogfr.2020.04.001_bib0505","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/jim-2017-000426","article-title":"Role of autophagy in tumor necrosis factor-alpha-induced apoptosis of osteoblast cells","volume":"65","author":"Zheng","year":"2017","journal-title":"J. Investig. Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0510","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1359\/jbmr.1998.13.5.793","article-title":"Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines","volume":"13","author":"Jilka","year":"1998","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.cytogfr.2020.04.001_bib0515","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1210\/endo.138.9.5370","article-title":"Multiple extracellular signals promote osteoblast survival and apoptosis","volume":"138","author":"Hill","year":"1997","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.cytogfr.2020.04.001_bib0520","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/154405910608501006","article-title":"Fluid shear stress inhibits TNFalpha-induced osteocyte apoptosis","volume":"85","author":"Tan","year":"2006","journal-title":"J. Dent. Res."},{"issue":"11","key":"10.1016\/j.cytogfr.2020.04.001_bib0525","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1002\/art.24920","article-title":"Tumor necrosis factor alpha and interleukin-1beta modulate calcium and nitric oxide signaling in mechanically stimulated osteocytes","volume":"60","author":"Bakker","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0530","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1359\/jbmr.2000.15.3.474","article-title":"Decreased nitric oxide levels stimulate osteoclastogenesis and bone resorption both in vitro and in vivo on the chick chorioallantoic membrane in association with neoangiogenesis","volume":"15","author":"Collin-Osdoby","year":"2000","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0535","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.bone.2007.07.019","article-title":"Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption","volume":"41","author":"Tan","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0540","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fimmu.2018.00234","article-title":"Monomeric C-reactive protein binds and neutralizes receptor activator of NF-kappaB ligand-induced osteoclast differentiation","volume":"9","author":"Jia","year":"2018","journal-title":"Front. Immunol."},{"issue":"47","key":"10.1016\/j.cytogfr.2020.04.001_bib0545","doi-asserted-by":"crossref","first-page":"48487","DOI":"10.1074\/jbc.R400025200","article-title":"C-reactive protein","volume":"279","author":"Black","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0550","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10753-011-9361-1","article-title":"Association between C-reactive protein and type 2 diabetes in a Tunisian population","volume":"35","author":"Belfki","year":"2012","journal-title":"Inflammation"},{"issue":"7","key":"10.1016\/j.cytogfr.2020.04.001_bib0555","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/jbmr.1915","article-title":"C-reactive protein, bone strength, and nine-year fracture risk: data from the Study of Women\u2019s Health Across the Nation (SWAN)","volume":"28","author":"Ishii","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0560","first-page":"435","article-title":"[Effects of C-reactive protein on bone marrow-derived endothelial progenitor cell function]","volume":"36","author":"Cui","year":"2008","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2015.12.021","article-title":"Effects of C-reactive protein on bone cells","volume":"145","author":"Cho","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0570","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fphys.2018.00504","article-title":"Role of toll-like receptor 4 on osteoblast metabolism and function","volume":"9","author":"Alonso-Perez","year":"2018","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.cytogfr.2020.04.001_bib0575","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.1074\/jbc.M206421200","article-title":"RANK ligand-induced elevation of cytosolic Ca2+ accelerates nuclear translocation of nuclear factor kappa B in osteoclasts","volume":"278","author":"Komarova","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0580","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jor.22200","article-title":"Blockade of JNK and NFAT pathways attenuates orthopedic particle-stimulated osteoclastogenesis of human osteoclast precursors and murine calvarial osteolysis","volume":"31","author":"Yamanaka","year":"2013","journal-title":"J. Orthop. Res."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0585","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/adip.27552","article-title":"Adipokines and insulin action: a sensitive issue","volume":"3","author":"Knights","year":"2014","journal-title":"Adipocyte"},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0590","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fendo.2013.00071","article-title":"Adipokines mediate inflammation and insulin resistance","volume":"4","author":"Kwon","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"11","key":"10.1016\/j.cytogfr.2020.04.001_bib0595","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.tem.2010.08.002","article-title":"Obesity and leptin resistance: distinguishing cause from effect","volume":"21","author":"Myers","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0600","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1467-789X.2006.00270.x","article-title":"The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review","volume":"8","author":"Klok","year":"2007","journal-title":"Obes. Rev."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0605","first-page":"187","article-title":"Leptin and bone metabolism","volume":"17","author":"Coen","year":"2004","journal-title":"J. Nephrol."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0610","first-page":"145","article-title":"Bone mass regulation of leptin and postmenopausal osteoporosis with obesity","volume":"9","author":"Legiran","year":"2012","journal-title":"Clin. Cases Miner. Bone Metab."},{"issue":"8","key":"10.1016\/j.cytogfr.2020.04.001_bib0615","doi-asserted-by":"crossref","first-page":"R576","DOI":"10.1152\/ajpregu.00017.2014","article-title":"Systemic leptin dose-dependently increases STAT3 phosphorylation within hypothalamic and hindbrain nuclei","volume":"306","author":"Maniscalco","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0620","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1743-7075-9-109","article-title":"Leptin differentially regulate STAT3 activation in ob\/ob mouse adipose mesenchymal stem cells","volume":"9","author":"Zhou","year":"2012","journal-title":"Nutr. Metab. (Lond)"},{"issue":"25","key":"10.1016\/j.cytogfr.2020.04.001_bib0625","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1073\/pnas.93.25.14564","article-title":"Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells","volume":"93","author":"Gainsford","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6696","key":"10.1016\/j.cytogfr.2020.04.001_bib0630","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/29795","article-title":"Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression","volume":"394","author":"Lord","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0635","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/313179","article-title":"Adiponectin provides cardiovascular protection in metabolic syndrome","volume":"2011","author":"Okamoto","year":"2011","journal-title":"Cardiol. Res. Pract."},{"issue":"10","key":"10.1016\/j.cytogfr.2020.04.001_bib0640","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1359\/jbmr.060707","article-title":"Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway","volume":"21","author":"Luo","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0645","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s12020-014-0216-z","article-title":"Adiponectin exerts its negative effect on bone metabolism via OPG\/RANKL pathway: an in vivo study","volume":"47","author":"Wang","year":"2014","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0650","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V96.5.1723","article-title":"Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages","volume":"96","author":"Yokota","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0655","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI29709","article-title":"Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies","volume":"117","author":"Takemura","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.cytogfr.2020.04.001_bib0660","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.cytogfr.2020.04.001_bib0665","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm724","article-title":"Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30","volume":"8","author":"Maeda","year":"2002","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.cytogfr.2020.04.001_bib0670","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1172\/JCI31021","article-title":"Obesity-associated improvements in metabolic profile through expansion of adipose tissue","volume":"117","author":"Kim","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"51","key":"10.1016\/j.cytogfr.2020.04.001_bib0675","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-kappaB: players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0680","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1359\/jbmr.2003.18.2.260","article-title":"Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption","volume":"18","author":"Xing","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0685","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000075","article-title":"A structural guide to proteins of the NF-kappaB signaling module","volume":"1","author":"Huxford","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"25","key":"10.1016\/j.cytogfr.2020.04.001_bib0690","doi-asserted-by":"crossref","first-page":"18245","DOI":"10.1074\/jbc.M610701200","article-title":"NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1","volume":"282","author":"Yamashita","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cytogfr.2020.04.001_bib0695","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nm1054","article-title":"Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo","volume":"10","author":"Jimi","year":"2004","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0700","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1302\/2046-3758.63.BJR-2016-0237.R1","article-title":"Ubiquitin E3 ligase Itch negatively regulates osteoblast function by promoting proteasome degradation of osteogenic proteins","volume":"6","author":"Liu","year":"2017","journal-title":"Bone Joint Res."},{"issue":"6","key":"10.1016\/j.cytogfr.2020.04.001_bib0705","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm.1954","article-title":"Inhibition of osteoblastic bone formation by nuclear factor-kappaB","volume":"15","author":"Chang","year":"2009","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0710","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/dc12-0702","article-title":"Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"36","author":"Wang","year":"2013","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.cytogfr.2020.04.001_bib0715","doi-asserted-by":"crossref","first-page":"E794","DOI":"10.1152\/ajpendo.00776.2009","article-title":"NF-kappaB activity in muscle from obese and type 2 diabetic subjects under basal and exercise-stimulated conditions","volume":"299","author":"Tantiwong","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.cytogfr.2020.04.001_bib0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023999","article-title":"Type 2 diabetes is associated with altered NF-kappaB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS","volume":"6","author":"Andreasen","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.cytogfr.2020.04.001_bib0725","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.4049\/jimmunol.0903131","article-title":"Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected]","volume":"184","author":"Penzo","year":"2010","journal-title":"J. Immunol."},{"issue":"16","key":"10.1016\/j.cytogfr.2020.04.001_bib0730","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1101\/gad.1958410","article-title":"Constitutively active NF-kappaB triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-independent inflammatory disease","volume":"24","author":"Dong","year":"2010","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0735","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12902-018-0283-x","article-title":"Type 2 diabetes affects bone cells precursors and bone turnover","volume":"18","author":"Sassi","year":"2018","journal-title":"BMC Endocr. Disord."},{"issue":"6","key":"10.1016\/j.cytogfr.2020.04.001_bib0740","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038694","article-title":"Constitutively active canonical NF-kappaB pathway induces severe bone loss in mice","volume":"7","author":"Otero","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0745","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MED.0b013e328350a6e1","article-title":"Type 2 diabetes and bone fractures","volume":"19","author":"Moseley","year":"2012","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0750","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.cytogfr.2020.04.001_bib0755","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00198-015-3088-z","article-title":"Changes in quality of life associated with fragility fractures: australian arm of the International Cost and Utility related to Osteoporotic Fractures Study (AusICUROS)","volume":"26","author":"Abimanyi-Ochom","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0760","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40842-018-0060-9","article-title":"Diabetes mellitus and bone health: epidemiology, etiology and implications for fracture risk stratification","volume":"4","author":"Valderrabano","year":"2018","journal-title":"Clin. Diabetes Endocrinol."},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0765","first-page":"3156","article-title":"Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia","volume":"17","author":"Li","year":"2011","journal-title":"Mol. Vis."},{"issue":"9","key":"10.1016\/j.cytogfr.2020.04.001_bib0770","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.2337\/dc06-0531","article-title":"Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes","volume":"29","author":"Stirban","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0775","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3389\/fphys.2018.01641","article-title":"Influence of physical exercise on advanced glycation end products levels in patients living with the human immunodeficiency virus","volume":"9","author":"Rodrigues","year":"2018","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.cytogfr.2020.04.001_bib0780","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.dsx.2010.05.004","article-title":"Physical activity reduces circulating TNF-alpha but not pro-thrombotic factors levels in patients with metabolic syndrome","volume":"4","author":"Paloma","year":"2010","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.cytogfr.2020.04.001_bib0785","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fphys.2018.00636","article-title":"Moderate exercise suppresses NF-kappaB signaling and activates the SIRT1-AMPK-PGC1alpha Axis to attenuate muscle loss in diabetic db\/db mice","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0790","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1476-5381.2012.02224.x","article-title":"Aerobic exercise reduces oxidative stress and improves vascular changes of small mesenteric and coronary arteries in hypertension","volume":"168","author":"Roque","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.cytogfr.2020.04.001_bib0795","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bjsports-2016-095999","article-title":"Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials","volume":"51","author":"Fedewa","year":"2017","journal-title":"Br. J. Sports Med."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0800","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/ajcn\/73.2.240","article-title":"Effect of long-term changes in diet and exercise on plasma leptin concentrations","volume":"73","author":"Reseland","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.04.001_bib0805","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2337\/diacare.27.2.629","article-title":"Exercise increases adiponectin levels and insulin sensitivity in humans","volume":"27","author":"Kriketos","year":"2004","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.cytogfr.2020.04.001_bib0810","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00062752-200105000-00002","article-title":"Exercise and interleukin-6","volume":"8","author":"Pedersen","year":"2001","journal-title":"Curr. Opin. Hematol."},{"issue":"2 Pt 2","key":"10.1016\/j.cytogfr.2020.04.001_bib0815","first-page":"R451","article-title":"Increased interleukin 1 beta in human skeletal muscle after exercise","volume":"257","author":"Cannon","year":"1989","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.cytogfr.2020.04.001_bib0820","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3803\/EnM.2018.33.4.435","article-title":"Effects of resistance exercise on bone health","volume":"33","author":"Hong","year":"2018","journal-title":"Endocrinol. Metab. Seoul (Seoul)"},{"issue":"1","key":"10.1016\/j.cytogfr.2020.04.001_bib0825","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/JES.0b013e318201f601","article-title":"A role for myokines in muscle-bone interactions","volume":"39","author":"Hamrick","year":"2011","journal-title":"Exerc. Sport Sci. Rev."},{"issue":"4","key":"10.1016\/j.cytogfr.2020.04.001_bib0830","first-page":"359","article-title":"Influence of skeletal muscles on the risk of falling in old age","volume":"58","author":"Schone","year":"2017","journal-title":"Internist (Berl)"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610120300502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610120300502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:57:24Z","timestamp":1761217044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610120300502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":166,"alternative-id":["S1359610120300502"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2020.04.001","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multifactorial effects of hyperglycaemia, hyperinsulinemia and inflammation on bone remodelling in type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2020.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}